PUBLISHER: Grand View Research | PRODUCT CODE: 1790480
PUBLISHER: Grand View Research | PRODUCT CODE: 1790480
U.S. Hemostasis Valve Market Size, Share & Trends Analysis Report By Type (Hemostasis Valve Y-Connectors, Double Y-Connector Hemostasis Valves), By Application, By End Use, And Segment Forecasts, 2025 - 2033
U.S. Hemostasis Valve Market Size & Trends:
The U.S. hemostasis valve market size was estimated at USD 64.47 million in 2024 and is projected to grow at a CAGR of 5.4% from 2025 to 2033.The market is experiencing significant growth due to several key factors, including the rising incidence of cardiovascular diseases, favorable regulatory support, an aging population, and ongoing technological advancements. A notable driver is the increasing preference for minimally invasive procedures, which offer advantages such as less pain, shorter hospital stays, quicker recovery, and a reduced risk of complications compared to traditional open surgeries.
This shift is fueling the demand for medical devices that support these techniques. Hemostasis valves play a critical role in minimally invasive catheter-based procedures by ensuring controlled blood flow and preventing leakage during interventions.
Air pollution is increasingly recognized as a major contributor to the rise in cardiovascular diseases. Both chronic and short-term exposures significantly raise the risk of cardiovascular emergencies and mortality in the U.S. The World Heart Report 2024 highlights that air pollution worsens all major cardiovascular diseases (CVDs). In 2019, nearly 70% of the 4.2 million deaths linked to ambient air pollution were due to cardiovascular issues, particularly ischemic heart disease (1.9 million deaths) and stroke (900,000 deaths). As a result, there is an increased need for diagnostic and therapeutic procedures such as angiography and angioplasty, where hemostasis valves play a crucial role in maintaining patient safety by regulating blood flow during catheter-based interventions.
Technological advancements in medical devices are pivotal in driving the market growth. Ongoing technological advancements are playing a key role in improving the performance and reliability of hemostasis valves. Manufacturers are continuously innovating to enhance valve design, material quality, and compatibility with a variety of catheter sizes and interventional tools. These improvements help reduce the risk of blood leakage, improve ease of use for clinicians, and enhance patient safety during minimally invasive procedures. For example, Merit Medical Systems offers advanced hemostasis valves such as the Merit AccessPLUS and Honor Hemostasis Valves, which are designed with ergonomic features, superior sealing mechanisms, and robust hemostatic control. These innovations reflect the industry's focus on optimizing procedural efficiency and reducing complications in catheter-based interventions.
U.S. Hemostasis Valve Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. hemostasis valve market report based on type, application, and end use:
- Type Outlook (Revenue, USD Million, 2021 - 2033)
- Hemostasis Valve Y- Connectors
- Double Y- Y-Connector Hemostasis Valves
- One-Handed Hemostasis Valves
- Others
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Angiography
- Angioplasty
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals
- Ambulatory Surgical Centers
- Others
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. Application
- 1.2.3. End Use
- 1.2.4. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Volume price analysis (Model 1)
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Application outlook
- 2.2.3. End Use outlook
- 2.3. Competitive Insights
Chapter 3. U.S. Hemostasis Valve Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Rising prevalence of coronary artery disease (CAD)
- 3.2.1.2. Advancements in technologies
- 3.2.1.3. Shift towards minimally invasive procedures
- 3.2.2. Market restraint analysis
- 3.2.2.1. Product recalls
- 3.2.2.2. Clinical complexity and procedural risks
- 3.2.1. Market driver analysis
- 3.3. U.S. Hemostasis Valve Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- 3.3.1. Industry Analysis - Porter's
Chapter 4. U.S. Hemostasis Valve Market: Type Estimates & Trend Analysis
- 4.1. U.S. Hemostasis Valve Market: Type Dashboard
- 4.2. U.S. Hemostasis Valve Market: Type Movement Analysis
- 4.3. U.S. Hemostasis Valve Market by Type, Revenue
- 4.4. Hemostasis Valve Y-Connectors
- 4.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 4.5. Double Y-Connector Hemostasis Valves
- 4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 4.6. One-Handed Hemostasis Valves
- 4.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 4.7. Others
- 4.7.1. Market estimates and forecast 2021 to 2033 (USD Million)
Chapter 5. U.S. Hemostasis Valve Market: Application Estimates & Trend Analysis
- 5.1. U.S. Hemostasis Valve Market: Application Dashboard
- 5.2. U.S. Hemostasis Valve Market: Application Movement Analysis
- 5.3. U.S. Hemostasis Valve Market by Application, Revenue
- 5.4. Angiography
- 5.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 5.5. Angioplasty
- 5.5.1. Market estimates and forecast 2021to 2033 (USD Million)
Chapter 6. U.S. Hemostasis Valve Market: End Use Estimates & Trend Analysis
- 6.1. U.S. Hemostasis Valve Market: End Use Dashboard
- 6.2. U.S. Hemostasis Valve Market: End Use Movement Analysis
- 6.3. U.S. Hemostasis Valve Market by End Use, Revenue
- 6.4. Hospitals
- 6.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 6.5. Ambulatory Surgical Centers
- 6.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
- 6.6. Others
- 6.6.1. Market estimates and forecast 2021 to 2033 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Manufacturers
- 7.2. Company/Competition Categorization
- 7.3. Vendor Landscape
- 7.3.1. Key company market share analysis, 2024
- 7.4. Company Profiles
- 7.4.1. Boston Scientific Corporation
- 7.4.1.1. Company overview
- 7.4.1.2. Financial performance
- 7.4.1.3. Product benchmarking
- 7.4.1.4. Strategic initiatives
- 7.4.2. Teleflex Incorporated
- 7.4.2.1. Company overview
- 7.4.2.2. Financial performance
- 7.4.2.3. Product benchmarking
- 7.4.2.4. Strategic initiatives
- 7.4.3. Merit Medical Systems
- 7.4.3.1. Company overview
- 7.4.3.2. Financial performance
- 7.4.3.3. Product benchmarking
- 7.4.3.4. Strategic initiatives
- 7.4.4. B. Braun
- 7.4.4.1. Company overview
- 7.4.4.2. Financial performance
- 7.4.4.3. Product benchmarking
- 7.4.4.4. Strategic initiatives
- 7.4.5. Terumo Corporation
- 7.4.5.1. Company overview
- 7.4.5.2. Financial performance
- 7.4.5.3. Product benchmarking
- 7.4.5.4. Strategic initiatives
- 7.4.6. Abbott
- 7.4.6.1. Company overview
- 7.4.6.2. Financial performance
- 7.4.6.3. Product benchmarking
- 7.4.6.4. Strategic initiatives
- 7.4.7. Argon Medical Devices
- 7.4.7.1. Company overview
- 7.4.7.2. Financial performance
- 7.4.7.3. Product benchmarking
- 7.4.7.4. Strategic initiatives
- 7.4.8. Freudenberg Medical
- 7.4.8.1. Company overview
- 7.4.8.2. Financial performance
- 7.4.8.3. Product benchmarking
- 7.4.8.4. Strategic initiatives
- 7.4.9. DeRoyal Industries, Inc.
- 7.4.9.1. Company overview
- 7.4.9.2. Financial performance
- 7.4.9.3. Product benchmarking
- 7.4.9.4. Strategic initiatives
- 7.4.10. Antmed Corporation
- 7.4.10.1. Company overview
- 7.4.10.2. Financial performance
- 7.4.10.3. Product benchmarking
- 7.4.10.4. Strategic initiatives
- 7.4.1. Boston Scientific Corporation
List of Tables
- Table 1 List of Abbreviations
- Table 2 List of secondary sources
- Table 3 U.S. Hemostasis Valve market, by type, 2018 - 2030 (USD Million)
- Table 4 U.S. Hemostasis Valve market, by application, 2018 - 2030 (USD Million)
- Table 5 U.S. Hemostasis Valve market, by end use, 2018 - 2030 (USD Million)
- Table 6 Participant's overview
- Table 7 Financial performance
- Table 8 Key companies undergoing expansions
- Table 9 Key companies undergoing acquisitions
- Table 10 Key companies undergoing collaborations
- Table 11 Key companies launching new services
- Table 12 Key companies undergoing partnerships
- Table 13 Key companies undertaking other strategies
List of Figures
- Fig. 1 Market research process
- Fig. 2 Information procurement
- Fig. 3 Primary research pattern
- Fig. 4 Market research approaches
- Fig. 5 Market formulation & validation
- Fig. 6 U.S. Hemostasis Valve market segmentation
- Fig. 7 Market snapshot, 2024
- Fig. 8 Market trends & outlook
- Fig. 9 Market driver relevance analysis (current & future impact)
- Fig. 10 Market restraint relevance analysis (current & future impact)
- Fig. 11 Swot analysis, by factor (political & legal, economic and technological)
- Fig. 12 Porter's five forces analysis
- Fig. 13 U.S. Hemostasis Valve market: Type Outlook Key Takeaways
- Fig. 14 U.S. Hemostasis Valve market: Type Movement Analysis
- Fig. 15 Hemostasis Valve Y-Connectors market, 2018 - 2030 (USD Million)
- Fig. 16 Double Y-Connector Hemostasis Valves market, 2018 - 2030 (USD Million)
- Fig. 17 One-Handed Hemostasis Valves market, 2018 - 2030 (USD Million)
- Fig. 18 Others market, 2018 - 2030 (USD Million)
- Fig. 19 U.S. Hemostasis Valve market: Application outlook key takeaways
- Fig. 20 U.S. Hemostasis Valve market: Application movement analysis
- Fig. 21 Angiography market, 2018 - 2030 (USD Million)
- Fig. 22 Angioplasty market, 2018 - 2030 (USD Million)
- Fig. 23 U.S. Hemostasis Valve market: End Use outlook key takeaways
- Fig. 24 U.S. Hemostasis Valve market: End Use movement analysis
- Fig. 25 Hospitals market, 2018 - 2030 (USD Million)
- Fig. 26 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
- Fig. 27 Others market, 2018 - 2030 (USD Million)
- Fig. 28 Strategy framework
